IRIS - Res&Arch Institutional Research Information System - Research & Archive

AGNELLI, Giancarlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.150
EU - Europa 8.835
AS - Asia 2.460
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 11
AF - Africa 7
OC - Oceania 2
Totale 22.477
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.086
UA - Ucraina 2.179
IE - Irlanda 2.146
IT - Italia 1.402
SE - Svezia 916
VN - Vietnam 681
SG - Singapore 640
FI - Finlandia 562
HK - Hong Kong 550
DE - Germania 486
RU - Federazione Russa 485
CN - Cina 330
GB - Regno Unito 220
TR - Turchia 147
FR - Francia 112
CH - Svizzera 76
CA - Canada 55
AT - Austria 51
BE - Belgio 41
NL - Olanda 37
UZ - Uzbekistan 35
LB - Libano 28
CZ - Repubblica Ceca 27
PL - Polonia 27
GR - Grecia 26
KR - Corea 24
EU - Europa 10
RO - Romania 8
SK - Slovacchia (Repubblica Slovacca) 8
BR - Brasile 6
MX - Messico 6
BG - Bulgaria 5
JP - Giappone 5
CL - Cile 4
ES - Italia 4
HR - Croazia 4
IQ - Iraq 4
EG - Egitto 3
IN - India 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BN - Brunei Darussalam 2
DK - Danimarca 2
EE - Estonia 2
LY - Libia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
CR - Costa Rica 1
EC - Ecuador 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RE - Reunion 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 22.477
Salva come PNG Salva come JPEG
Città #
Chandler 2.342
Dublin 2.139
San Mateo 1.222
Jacksonville 1.132
Dong Ket 681
Altamura 671
Medford 576
Princeton 574
Hong Kong 548
Lawrence 501
Des Moines 485
Wilmington 395
Ann Arbor 383
Singapore 383
Andover 360
Perugia 329
Ashburn 188
Saint Petersburg 174
Beijing 153
Izmir 144
Norwalk 112
San Paolo di Civitate 93
Helsinki 91
Los Angeles 87
Shanghai 70
Boardman 67
Redmond 66
Rome 51
Brussels 41
Moscow 41
Woodbridge 39
Falls Church 36
Dearborn 34
Ottawa 32
Redwood City 29
Den Haag 25
New York 25
Houston 24
Seoul 23
Auburn Hills 20
Amelia 16
Philadelphia 16
Hanover 14
Santa Clara 14
Brno 13
Lausanne 13
Edinburgh 12
Frankfurt Am Main 12
Bareggio 10
Chicago 9
Lappeenranta 9
Olomouc 9
Amsterdam 8
Bratislava 8
Vienna 8
Kiev 7
Seattle 7
Milan 6
Paris 6
Ponte 6
Buffalo 5
Clifton 5
Montreal 5
London 4
Nürnberg 4
Parabiago 4
Simi Valley 4
Timisoara 4
Toledo 4
Toronto 4
Zagreb 4
Athens 3
Bologna 3
Chengdu 3
Faenza 3
Grottammare 3
Kocaeli 3
Pasadena 3
Pioltello 3
San Diego 3
Secaucus 3
Sofia 3
Stockholm 3
Terni 3
Umbertide 3
Yorktown 3
Auckland 2
Bandar Seri Begawan 2
Belfiore 2
Belo Horizonte 2
Birmingham 2
Castello di Godego 2
Clearwater 2
Corciano 2
Córdoba 2
Dallas 2
Fairfield 2
Falkenstein 2
Fremont 2
Garbagnate Milanese 2
Totale 14.709
Salva come PNG Salva come JPEG
Nome #
Epidemiology of cerebral vein and sinus thrombosis. 85
Secondary stroke prevention in women. 85
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 82
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 78
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter related deep vein thrombosis in a child with acute lymphoblastic leukemia 76
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 75
Risk factors for venous thromboembolism in the elderly: results of the master registry. 75
Isolated monoparesis following stroke 74
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. 73
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome. 73
Lessons learned from the global orthopaedic registry: study design, current practice patterns, and future directions. 72
Risk factor for upper limb deep vein thrombosis 72
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 72
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 71
[Spinal anesthesia and prophylaxis of venous thromboembolism. Results of a national survey]. 71
Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. 71
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 71
Gene-drug interaction in stroke. 70
Prevention of venous thromboembolism in surgical patients 70
Acute stroke symptoms: Do differences exist between sexes? 70
Vascular cognitive impairment: a pragmatic concept 68
Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study 68
Early admission to stroke unit influences clinical outcome 68
Arterite temporale occulta: contributo casistico e revisione della letteratura 68
The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: influence of dosage regimens in rabbits. 68
Spotlight: Giancarlo Agnelli, MD. Interview by Emma Baines. 68
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients 67
Risk factors for adverse short-term outcome in patients with pulmonary embolism 67
Dermatan sulphate in patients with heparin-induced thrombocytopenia. 67
Aspirin for preventing the recurrence of venous thromboembolism. 67
Acute pulmonary embolism: risk stratification in the emergency department. 67
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. 66
A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. 66
A hybrid plasminogen activator binds to the u-PA receptor and has a reduced thrombolytic potency in vivo. 66
Current role of venography in the diagnosis of deep-vein thrombosis. 66
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 66
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 66
Thrombolysis in submassive pulmonary embolism 66
Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study. 65
Letter 3: Meta-analysis of trials comparing ximegatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery 65
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 65
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project 65
Initial treatment of venous thromboembolism 64
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome. 64
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. 63
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 63
Activation of blood coagulation in patients undergoing postoperative blood salvage and reinfusion of unwashed whole blood after total knee arthroplasty 62
Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery 62
Venous thromboembolism and atherosclerosis: common denominators or different diseases? 62
Attitudes to prescribing compression stockings for patients with acute DVT: the MASTER registry. 62
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. 62
Intramuscular dermatan sulfate MF701 in patients with hip fracture: relationship between pharmacokinetics and antithrombotic efficacy. 62
Anticoagulant agents in the management of pulmonary embolism. 62
New pharmacologic strategies for arterial and venous thromboembolism 61
Current issues in anticoagulation 61
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? 61
Clinical potential of oral direct thrombin inhibitors in the prevention and treatment of venous thromboembolism 61
Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: a metanalysis 60
Heparin reduces venous thromboembolism in neurosurgery but increases the risk of bleeding. (Iorio A, Agnelli G. Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis. Arch Intern Med. 2000;160:2327-2332) 60
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy 60
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence 60
A prospective study on cardiovascular events after acute pulmonary embolism 60
Prevention of venous thromboembolism in high risk patients. 60
[Acute immunoallergic thrombopenia due to sulfamethoxazole-trimethoprim]. 60
[Effect of platelet-derived growth factor on the in vitro cell proliferation of chick embryo skin]. 60
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 60
Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. 59
Effects of a stable prostacyclin analogue on platelet activity and on host immunocompetence in mice. 59
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study. 59
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 59
Randomised double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers 59
Antithrombotic therapy for venous thrombosis disease. 58
ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS 58
Acute pulmonary embolism. 58
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 58
Antithrombotic therapy for venous thromboembolic disease. 58
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 58
Intravenous thrombolysis in acute myocardial infarction 57
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY 57
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 57
Statins and stroke prevention. 57
What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? 57
Clinical outcome of orthopaedic patients with negative lower limb venography at discharge. 57
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery. 57
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 57
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. 56
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. 56
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 56
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 56
Outcome in patients with stroke associated with internal carotid artery occlusion 55
New anticoagulants 55
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 55
Combined oral anticoagulants and antiplatelets: benefits and risks. 55
Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the Global Registry of Acute Coronary Events. 55
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 55
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 55
Recurrent venous thromboembolism in men and women 54
Profilassi della trombosi venosa profonda in neurochirurgia 54
Role of fibrinolysis and interventional therapy for acute venous thromboembolism 54
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. 54
Totale 6.347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.277
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.836 20 41 328 12 319 33 327 53 367 171 44 121
2020/20214.241 19 341 94 337 1.438 141 249 36 424 96 334 732
2021/20224.446 53 780 64 153 232 31 46 1.540 68 167 469 843
2022/20238.339 663 1.638 121 542 651 1.170 21 340 2.832 23 264 74
2023/20242.458 205 309 189 40 47 22 475 123 164 119 427 338
2024/202544 44 0 0 0 0 0 0 0 0 0 0 0
Totale 23.480